Found 8 results

Name Type of Offering Accepted Date
Adaptive Phage Therapeutics, Inc. See All Filings
D 2020-06-19 20:57:07
Amount To Be Raised $7,000,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-06-19 20:57:07
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings
D 2018-06-04 18:26:28
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-18-000002
Exclusions or Exemptions 506b
Accepted Date 2018-06-04 18:26:28
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings
D 2023-06-09 14:07:23
Amount To Be Raised $30,000,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001979814-23-000002
Exclusions or Exemptions 506b
Accepted Date 2023-06-09 14:07:23
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Equity
Adaptive Phage Therapeutics, Inc. See All Filings
D/A 2020-08-27 12:32:31
Amount To Be Raised $3,650,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-20-000003
Exclusions or Exemptions 506c
Accepted Date 2020-08-27 12:32:31
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings
D 2021-05-20 13:29:13
Amount To Be Raised $53,262,037
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-21-000001
Exclusions or Exemptions 506b
Accepted Date 2021-05-20 13:29:13
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Equity
Adaptive Phage Therapeutics, Inc. See All Filings
D 2017-04-13 17:42:13
Amount To Be Raised $3,000,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-04-13 17:42:13
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Equity
Adaptive Phage Therapeutics, Inc. See All Filings
D/A 2019-11-27 12:38:47
Amount To Be Raised $7,000,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-19-000002
Exclusions or Exemptions 506b
Accepted Date 2019-11-27 12:38:47
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings
D 2020-08-24 10:02:42
Amount To Be Raised $7,000,000
Associated Brokers / Dealers N/A
CIK Number 0001701259
Filed Document 0001701259-20-000002
Exclusions or Exemptions 506c
Accepted Date 2020-08-24 10:02:42
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MARYLAND
Revenue or Assets Decline to Disclose
Type of Security Debt